NSDL, India's largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
12h
Hosted on MSNHow To Invest in the ThoughtSpot IPO: A Beginner’s GuideInvesting in ThoughtSpot’s IPO might be a good move to add to your portfolio, It has beating out competitors other analytics ...
Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.
Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...
Hosted on MSN17h
Krispy Kreme (DNUT) Stock Trades Down, Here Is WhyWhat Happened? Shares of doughnut chain Krispy Kreme (NASDAQ:DNUT) fell 26.1% in the pre-market session after the company ...
Bgin Blockchain plans a $50M IPO to expand crypto mining amid growth, but faces market volatility, legal disputes, and risks.
A brief history of Netflix stock. Netflix was founded in 1997 as a competitor to Blockbuster, operating a DVD-by-mail rental ...
Nearly half of the new-age companies listed since 2021 are trading below their IPO price. This and more in today’s ETtech Top ...
Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...
The U.S. IPO market seems to be cooling off this week, with no major listing planned. This week, Advanced Biomed ( ADVB) is ...
Paytm, Delhivery, and Honasa are the top losers, while Zomato and PB Fintech have stood up successfully against the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results